Press Release Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting Aug 4
Press Release Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference Jul 31